Dave Fornell, ITN Editor at RSNA
Dave Fornell, ITN Editor at RSNA

Dave Fornell is the editor of Imaging Technology News magazine and Diagnostic & Interventional Cardiology magazine.

Blog | Dave Fornell, ITN Editor at RSNA | RSNA 2017 | January 18, 2018 | Dave Fornell

The Top Trends at RSNA 2017

The Radiological Association of North America's (RSNA) 2017 conference will be remembered as the year artificial intelligence (AI) exploded in radiology. It was by far the biggest news and overall trend in sessions and throughout the expo floor. The key message was AI is here to help and augment radiologists, not replace them. The majority of the AI examples on the show floor run in the background of radiology IT systems to aid workflow, not offer its own clinical findings. 

Here are links to ITN’s coverage of AI at RSNA 2017:

VIDEO: Technology Report: Artificial Intelligence at RSNA 2017

 

Why AI By Any Name Is Sweet For Radiology 

VIDEO: Deep Learning is Key Technology Trend at RSNA 2017

VIDEO: How Utilization of Artificial Intelligence Will Impact Radiology

VIDEO: Examples of How Artificial Intelligence Will Improve Medical Imaging

 

Contributing editor and radiology industry expert Greg Freiherr offers insights about the key trends and technologies at RSNA in the following content:

Value in Radiology Takes on Added Depth at RSNA 2017

• RSNA 2017: Often Real Systems (Were) Not Available

 

RSNA is radiology’s premier conference of the year and is used to launch hundreds of new products and to show work-in-progress technologies. Take a tour of some of these technologies in the VIDEO “Editor's Choice of the Most Innovative New Imaging Technology at RSNA 2017.”

One of the big issues facing radiology is the potential safety regarding MRI gadolinium contrast retention. The takeaway message from attending numerous sessions and interviews on this topic is that more data is needed from large-scale, long-term patient studies. So far none of these have been established. Additionally, radiology has done a poor job of recording in the patient record what the contrast doses were or even what contrast agent was used. It is hard to conclude if there are any safety issues from incomplete or missing data and only relying on patients complaining of symptoms that may or may not be related to their MRIs. I met with two of the top RSNA MRI experts and you can watch the video interviews with Max Wintermark, M.D., professor of radiology and chief of neuroradiology, Stanford Hospital and Clinics, and Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pittsburgh Medical Center.

You can read an additional overview blog about the the current state of the gadolinium safety question, “Radiology Has Failed to Properly Assess or Track MRI Gadolinium Contrast Safety.”

Here is a link to all the key RSNA 2017 study presentations, trends and and videos

See what products vendors displayed at RSNA 2017 with listings by modality on the ITN FastPass microsite at www.rsnafastpass.com.

 

Related Content

he U.S. Food and Drug Administration (FDA) has issued a final order to reclassify medical image analyzers applied to mammography breast cancer, ultrasound breast lesions, radiograph lung nodules and radiograph dental caries detection, postamendments class III devices (regulated under product code MYN), into class II (special controls), subject to premarket notification

Image courtesy of iCAD

News | Computer-Aided Detection Software | January 22, 2020
January 22, 2020 — The U.S.
Iodine-based CT contrast ready for scanning with a Canon Aquilion One 320-slice CT system at Northwestern Medicine Central DuPage Hospital in the Chicago suburbs.
News | Radiology Imaging | January 22, 2020
January 22, 2020 — The risk of administering modern...
Medical imaging technology company Oxipit announced partnership with Swiss medical distribution company Healthcare Konnect to bring ChestEye AI imaging suite to healthcare institutions in Nigeria
News | Artificial Intelligence | January 22, 2020
January 22, 2020 — Medical imaging technology company Oxipit ann
Hitachi Healthcare Americas announced that it will create a new dedicated research and development facility within its North American headquarters facility in Twinsburg, Ohio
News | Radiology Business | January 21, 2020
January 21, 2020 — Hitachi Healthcare Americas announced that it will create a new dedicated research and development
Sponsored Content | Videos | Enterprise Imaging | January 20, 2020
GE Healthcare's iCenter is a cloud-based management software that provides 24/7 visibility to customers' visual and o
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Gadolinium based contrast dye in brain MRI

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

News | Contrast Media | January 17, 2020
January 17, 2020 — Bracco Diagnostics Inc., the U.
Carestream’s X-ray digital tomosynthesis functionality creates three-dimensional datasets from digital radiography (DR) that can be scrolled through similar to computed tomography (CT) imaging. It received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in January 2020. Digital tomosynthesis uses a single sweep of X-ray exposures and streamlines operator workflow by separating the process of DT exposure acquisition from image volume formation.
News | Digital Radiography (DR) | January 15, 2020
January 15, 2020 — Carestream’s X-ray digital tomosynthesis (DT) functionality, which creates three-dimensional datas